Trial intelligence / Profile preview

Autologous Chondrocytes for TMJ Condylar Resorption

NCT03137914Phase 1Completed

Sponsor
Faculdade de Medicina de Petrópolis
Start
May 2015
Primary completion
May 2016
Modality
Bone Marrow HSCs, Peripheral Blood HSCs
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of autologous cultured chondrocytes in Idiopathic Condylar Resorption (ICR), sponsored by Faculdade de Medicina de Petrópolis. Primary endpoint: Clinical improvement of the research participant after cell transplantation at 12 months. Started May 2015; status: completed.

02

Drugs

autologous cultured chondrocytes
03

Conditions

Idiopathic Condylar Resorption (ICR)

Beyond the preview

Go deeper on NCT03137914.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03137914.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call